+91-8668442535

Cell Surface Markers Market By Type (Flow Cytometers, Hematology Analyzers, Reagents And Kits), By Application (Drug Discovery, Disease Diagnosis), By End Users (Diagnostic Laboratories, Research And Academia) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

The cell surface markers market is set to reach US$ 33,712.7 million by 2026 from US$ 16,586.7 million in 2017, showcasing progressive growth at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. Technological advancements in the production of monoclonal antibodies and the manufacturing of cell-specific antibodies for disease diagnosis and prognosis are the major factors driving the cell surface markers market.

Pharmaceutical companies manufacture staining dyes and reagents used in determining specific cytological protocols, which drives the cell surface markers market growth. The cell surface markers market is limited by the frequent occurrence of false positive results and the fierce competition from new-generation sequencing techniques for drug discovery and disease diagnosis.

Market Synopsis

Increasing demand for targeted drug delivery and stem cell research will have a positive impact on the flow cytometer market.

Reagents and kits are currently dominating the cell surface markers market by type segment on account of their application in determining microscopic cellular functions. They are widely used in understanding the cell signaling pathways and pharmacodynamic activities taking place at the G-protein coupled receptors, etc. The reagents and kits are used to decipher cellular activities by antigen-antibody reactions such as agglutination reactions, precipitation reactions, complement fixation, enzyme-linked immunosorbent assays (ELISA), and immunofluorescence. Flow cytometers are widely used to identify the cell population of hematopoietic stem cells such as CD19, CD20, CD4, and CD34+ in biological samples in order to better understand cell migration in diabetes and cardiovascular disease.

Increasing the use of cell surface markers in developing monoclonal antibodies to treat chronic diseases will boost the drug discovery segment.

Cell surface markers are proteins that are expressed on the cell surface and are helpful in identifying the lineage and differentiation stages. In the present scenario, cell surface markers find huge demand in drug discovery and development as they help in analyzing epigenetic modification, gene regulation, and genotyping. The rising prevalence of chronic diseases, combined with increased public health awareness, has resulted in a growing need for cell surface markers in disease diagnosis.

Development of immunoassays for biological sample quantification to drive the diagnostic laboratories market

In the last two decades, there has been tremendous technological advancement in the development of immunoassays for the quantification of biological samples. Cell surface markers are widely employed by pathologists in performing clinical and forensic investigations, which has a positive impact on the market growth of diagnostic laboratories. Cell surface markers are utilized by aspiring researchers in academia to understand the disease etiology of chronic idiopathic diseases and to develop novel medicines for their treatment.

The growing number of diagnostic laboratories in the Asia Pacific will drive the cell surface markers market.

The rising incidence of chronic diseases and the existence of a well-developed healthcare infrastructure are responsible for the dominance of North America in the market for cell surface markers. The presence of market leaders such as Abbott Laboratories, Inc. and F. Hoffmann-La Roche AG. determines the cell surface marker market in Europe. Asia Pacific will register impressive growth throughout the forecast period owing to the increasing number of diagnostic laboratories and enhanced government funding for establishing new research and academic centers.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

A market assessment was performed to determine the market estimation and compounded annual growth rate (CAGR) for the report on the cell surface markers market. The market is divided into four sections: type, application, end users, and geography.

Quantitative analysis was performed to determine the existing market trends prevalent in the cell surface markers market. The competitive landscape is deciphered to get a gist of the technological advancement taking place in the cell surface marker market. In the latest news development segment, importance has been given to highlighting the major mergers and acquisitions and other growth strategies adopted by major players. Different types of reagents and kits used in drug discovery and disease diagnosis are covered in the product portfolio segment. The major players in the cell surface markers market are Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., F.Hoffman La-Roche AG, Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation, and Thermo Fisher Scientific, Inc.

Key questions are answered in this report.

  • What are the latest market trends existing in the cell surface markers market?
  • Who are the major players dominating the cell surface markers market?
  • What will be the market estimation and compound annual growth rate (CAGR) for the forecast period from 2018 to 2026?
  • What are the organic and inorganic market strategies adopted by key players?
  • What are the drivers and restraints of the cell surface marker market?
  • Which is the leading and fastest-growing segment by type in the cell surface marker market?
  • Which is the leading and fastest-growing segment by application?
  • Which is the leading and fastest-growing segment among end users?
  • Which is the leading and fastest-growing regional segment?

Frequently Asked Questions:

The market for Cell Surface Markers Market is expected to reach US$ 33,712.7 Mn by 2026.

The Cell Surface Markers Market is expected to see significant CAGR growth over the coming years, at 8.2%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., F.Hoffman La-Roche AG, Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation, and Thermo Fisher Scientific, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Sep 2018
Category:  Pharmaceuticals
Report ID:   59319
Report Format:   PDF
Pages:   120
Rating:    4.4 (58)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support